Chemours (CC) EBT (2014 - 2026)

Chemours has reported EBT for 13 years, with the latest figure at -$1.0 million in Q2 2026.

• On a quarterly basis, EBT rose 99.6% year-over-year to -$1.0 million in Q2 2026; TTM through Jun 2026 was -$52.0 million, a 81.36% increase from a year earlier, with the FY2025 full-year figure at -$453.0 million, down 239.81% from the prior year.
• EBT was -$1.0 million for Q2 2026 at Chemours, up from -$22.0 million in the prior quarter.
• The five-year high for EBT was $299.0 million in Q3 2022, with the low at -$433.0 million in Q2 2023.
• Average EBT over 5 years is $13.6 million, with a median of $1.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: EBT soared 425.0% in 2022, then tumbled 6800.0% in 2025.
• Over 5 years, EBT stood at -$69.0 million in 2022, then fell by 2.9% to -$71.0 million in 2023, then soared by 101.41% to $1.0 million in 2024, then sank by 6800.0% to -$67.0 million in 2025, then surged by 98.51% to -$1.0 million in 2026.
• The last three EBT figures came in at -$1.0 million (Q2 2026), -$22.0 million (Q1 2026), and -$67.0 million (Q4 2025), per Business Quant data.